Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Congress 2023

20 - 24 Oct 2023

Madrid, Spain

ESMO-Congress-2023-1000x1000

Resources are available according to the presenters' agreement to release them.

  • Abstracts and ePosters are open access.
  • Slides and webcasts are reserved to ESMO Members and registered Delegates.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

For healthcare professionals, researchers, and those interested in the ever-evolving field of cancer research and care

A comprehensive update covering recent breakthroughs in basic science, translational research, and clinical study results, as well as prevention, screening, and early diagnosis. The programme aimed at helping participants to understand the clinical implications of these advancements, especially in cancer biology, diagnostics, treatments, and educate on the optimal use of new diagnostic tools and therapies for patients with cancer. Abstract Book of the ESMO Congress 2023


Video coverage: Highlights    Expert reports    Breaking Science in Breast Cancer 
ESMO Members, read our Congress Watch articles

Quick access to special sessions

Clinical Practice Guidelines sessions (open to ESMO account holders):
- Session 1  covering early Breast Cancer, Oncogene-addicted mNSCLC, Pancreatic Cancer
- Session 2 covering non-oncogene-addicted mNSCLC, SCCHN, Prostate Cancer

ESMO Colloquia slides & webcasts

Satellite webcasts from our Industry partners

Hide
Filter by:

There are 3484 resources available

Audience Q&A

Presenter: All Speakers

Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates

Resources:

Webcast

Concluding Remarks

Presenter: Javier Cortés

Session: AstraZeneca - Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates

Resources:

Webcast

Summary and close

Presenter: Ignacio Duran Martinez

Session: Astellas Pharma Europe Ltd - The evolving treatment landscape in LA/mUC

Resources:

Webcast

Closing Remarks

Presenter: Salvatore Siena

Session: Seagen - HER2-Targeted Therapies in mCRC: Are We Ready for a Paradigm Shift?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.